|
|
LETTER TO THE EDITOR |
|
Year : 2020 | Volume
: 68
| Issue : 10 | Page : 2308 |
|
Viral shedding in tears of COVID-19 cases presenting as conjunctivitis
Ruchi Goel, Ritu Arora, Mohit Chhabra, Sumit Kumar
Department of Ophthalmology (Guru Nanak Eye Centre), Maulana Azad Medical College, New Delhi, India
Date of Web Publication | 23-Sep-2020 |
Correspondence Address: Dr. Ruchi Goel Department of Ophthalmology (Guru Nanak Eye Centre), Maulana Azad Medical College, New Delhi - 110 002 India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_2567_20
How to cite this article: Goel R, Arora R, Chhabra M, Kumar S. Viral shedding in tears of COVID-19 cases presenting as conjunctivitis. Indian J Ophthalmol 2020;68:2308 |
Dear Editor:
Conjunctivitis as a presenting feature of coronavirus disease (COVID-19) is well-known.[1],[2] All these cases may not develop respiratory symptoms.[3]
Herein, we present two patients of unilateral viral conjunctivitis; a 46-year-old female (case 1) and a 30-year-old male (case 2).
Nasopharyngeal (NP) and conjunctival swab (from the involved eye) were sent for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleotides by real-time polymerase chain reaction (RT-PCR) 2 days after the onset of conjunctivitis. A specimen was considered positive if the amplification curve for the E gene crossed the threshold line within 35 cycles and was positive for RdRp or ORF 1b gene assay.[4] The viral load was assessed using the cycle threshold (Ct) value of the E gene. The Ct value of genes E, ORF, and RdRp of NP swab and a conjunctival swab of case 1 and NP swab of case 2 were 16, 18, 24; 21, 21, 29; and 32, 35, 0, respectively. The conjunctival swab was negative in case 2.
Disturbance of conjunctival epithelial cells by respiratory pathogens can result in an adaptive immune response resulting in inflammation of the ocular surface.[5] The pathogens, while in tears, if not neutralized by the local mechanisms can infect the respiratory tissues. Subsequent systemic manifestation possibly depends upon the innate immunity of the patient.
Presence of viral RNA in the tears in case 1 could be related to the high viral load, evident by low Ct value of NP swab and absence in case 2, could be due to low viral load as indicated by high Ct value of NP swab. To our knowledge, this is the first report of tear positivity in COVID-19 case with conjunctivitis in the absence of systemic symptoms.
Therefore, patients of conjunctivitis with lower Ct values of NP swab could be silent spreaders of COVID-19 through tears and should be investigated for SARS-CoV-2 disease.
Acknowledgements
We are grateful to Dr Vikas Manchanda MD and Dr Sonal Saxena MD, Advanced Virology laboratory, Maulana Azad Medical College, New Delhi, India for conducting the RT-PCR for SARS-CoV-2.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | | |
1. | Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol 2020;10.1111/aos. 14445. doi: 10.1111/aos.14445. |
2. | Shetty R, D'Souza S, Lalgudi VG. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic? Indian J Ophthalmol 2020;68:683-7. [ PUBMED] [Full text] |
3. | Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases 2020;20:e00774. |
4. | |
5. | Creager HM, Kumar A, Zeng H, Maines TR, Tumpey TM, Belser JA. Infection and replication of influenza virus at the ocular surface. J Virol 2018;92:e02192-17. |
This article has been cited by | 1 |
COVID-19 and the Human Eye: Conjunctivitis, a Lone COVID-19 Finding – A Case-Control Study |
|
| Valeria Mocanu, Dharmesh Bhagwani, Abhinav Sharma, Claudia Borza, Ciprian Ilie Rosca, Morariu Stelian, Shalini Bhagwani, Laura Haidar, Lajwanti Kshtriya, Nilima Rajpal Kundnani, Florin-Raul Horhat, Raluca Horhat | | Medical Principles and Practice. 2022; | | [Pubmed] | [DOI] | | 2 |
Eye damage in COVID-19. Part 1: Involvement of the eye in SARS-CoV-2 virus transmission and anterior segment complications |
|
| N. I. Kurysheva, O. A. Pererva, A. D. Nikitina | | Russian Ophthalmological Journal. 2022; 15(4): 156 | | [Pubmed] | [DOI] | | 3 |
COVID-19 case presented initially with keratoconjunctivitis: A case report |
|
| Mohammed Alnajjar, Abdulrahman Al-Mashdali, Nedia Nefatti | | Annals of Medicine and Surgery. 2021; 71: 102957 | | [Pubmed] | [DOI] | | 4 |
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2 |
|
| Francesca Salamanna, Melania Maglio, Maria Paola Landini, Milena Fini | | Frontiers in Medicine. 2020; 7 | | [Pubmed] | [DOI] | | 5 |
Nosocomial COVID-19 transmission in routine ophthalmic practice—Is there new evidence? |
|
| SantoshG Honavar | | Indian Journal of Ophthalmology. 2020; 68(10): 2059 | | [Pubmed] | [DOI] | |
|
|
|
|